Peripheral Nerve Axon Involvement in Myotonic Dystrophy Type 1, Measured Using the Automated Nerve Excitability Test
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose: Primary involvement of the peripheral nerves in myotonic dystrophy type I (MyD1) is controversial. We investigated whether the involvement of peripheral nerves is a primary event of MyD1 or secondary to another complication such as diabetes mellitus (DM). Methods: The subjects comprised 12 patients with MyD1, 12 with DM and no peripheral nerve involvement, and 25 healthy volunteers. We measured multiple excitability indices in the median motor axons. The strength-duration time constant was calculated from the duration-charge curve,the threshold electrotonus and current-threshold relationships were calculated from the sequential subthreshold current, and the recovery cycle was derived from double suprathreshold stimulation. Results: The depolarizing and hyperpolarizing threshold electrotonus were significantly reduced and exhibited increased refractoriness in the MyD1 group compared with the DM and control groups. The SDTC, superexcitability, and subexcitability were not significantly altered in the MyD1group. Conclusions: The MyD1 group exhibited a depolarized axonal membrane potential. The significant differences in peripheral nerve excitability between the MyD1 group and the DM and normal control groups suggest that peripheral neuropathy is a primary event in MyD1 rather than a secondary complication of DM.
Abstract
Background and Purpose: Primary involvement of the peripheral nerves in myotonic dystrophy type I (MyD1) is controversial. We investigated whether the involvement of peripheral nerves is a primary event of MyD1 or secondary to another complication such as diabetes mellitus (DM). Methods: The subjects comprised 12 patients with MyD1, 12 with DM and no peripheral nerve involvement, and 25 healthy volunteers. We measured multiple excitability indices in the median motor axons. The strength-duration time constant was calculated from the duration-charge curve,the threshold electrotonus and current-threshold relationships were calculated from the sequential subthreshold current, and the recovery cycle was derived from double suprathreshold stimulation. Results: The depolarizing and hyperpolarizing threshold electrotonus were significantly reduced and exhibited increased refractoriness in the MyD1 group compared with the DM and control groups. The SDTC, superexcitability, and subexcitability were not significantly altered in the MyD1group. Conclusions: The MyD1 group exhibited a depolarized axonal membrane potential. The significant differences in peripheral nerve excitability between the MyD1 group and the DM and normal control groups suggest that peripheral neuropathy is a primary event in MyD1 rather than a secondary complication of DM.
참고문헌 (24)
- Harley HG, "Unstable DNA sequence in myotonic dystrophy", Lancet, 339, pp.1125~1128 (1992)
- Meola G, "Myotonic disorder: Myotonic dystrophy and proximal myotonic myopathy in: Muscle diseases", pp.115~134 (1999), Butterworth-Heinemann
- Caccia MR, "Myotonic dystrophy with neural involvement", J Neurol Sci, 16, pp.253~269 (1972)
- McComas AJ, "Incidence, severity, and time-course of motoneurone dysfunction in myotonic dystrophy: their significance for an understanding of anticipation", J Neurol Neurosurg Psychiatry, 41, pp.882~893 (1978)
- Jamal GA, "Myotonic dystrophy. A reassessment by conventional and more recently introduced neurophysiological techniques", Brain, 109, pp.1279~1296 (1986)
- Olson ND, "Peripheral neuropathy in myotonic dystrophy. Relation to glucose intolerance", Arch Neurol, 35, pp.741~745 (1978)
- Paramesh K, "Early onset myotonic dystrophy in association with polyneuropathy", J Neurol Neurosurg Psychiatry, 38, pp.1136~1139 (1975)
- Perseghin G, "Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy", Diabetes Care, 26, pp.2112~2118 (2003)
- Logullo F, "Peripheral neuropathy in myotonic dystrophy: electrophysiological and clinical features", Electromyogr Clin Neurophysiol, 32, pp.515~520 (1992)
- Roohi F, "Slow motor nerve conduction in myotonic dystrophy", Electromyogr Clin Neurophysiol, 21, pp.97~105 (1981)
- Bril V, "NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy", Eur Neurol, 41(Suppl 1), pp.8~13 (1999)
- Feldman EL, "A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy", Diabetes Care, 17, pp.1281~1289 (1994)
- Mogyoros I, "Strength-duration properties of human peripheral nerve", Brain, 119, pp.439~447 (1996)
- Z’Graggen WJ, "Nerve excitability changes in critical illness polyneuropathy", Brain, 129, pp.2461~2470 (2006)
- Dyck PJ, "Severity and staging of diabetic polyneuropathy in: Textbook of diabetic neuropathy", pp.170~175 (2003), Georg Thieme Verlag
- Krishnan AV, "Axonal function and activity-dependent excitability changes in myotonic dystrophy", Muscle Nerve, 33, pp.627~636 (2006)
- Cros D, "Serratrice G. Peripheral neuropathy in myotonic dystrophy: a nerve biopsy study", Ann Neurol, 23, pp.470~476 (1988)
- De Freitas GR, "Sural nerve biopsy in myotonic muscular dystrophy", Arq Neuropsiquiatr, 54, pp.19~24 (1996)
- Mondelli M, "Axonal motor and sensory neuropathy in myotonic dystrophy", Acta Neurol Scand, 88, pp.141~148 (1993)
- Pfeilsticker BH, "Electrophysiological evaluation in myotonic dystrophy: correlation with CTG length expansion", Arq Neuropsiquiatr, 59, pp.186~191 (2001)
- Kuwabara S, "Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease", Curr Neurovasc Res, 1, pp.373~379 (2004)
- Misawa S, "Axonal potassium conductance and glycemic control in human diabetic nerves", Clin Neurophysiol, 116, pp.1181~1187 (2005)
- Misawa S, "Strength-duration properties and glycemic control in human diabetic motor nerves", Clin Neurophysiol, 116, pp.254~258 (2005)
- Misawa S, "Hyperglycemia alters refractory periods in human diabetic neuropathy", Clin Neurophysiol, 115, pp.2525~2529 (2004)